<DOC>
	<DOCNO>NCT01857947</DOCNO>
	<brief_summary>The purpose study determine whether pro-adrenomedullin ( Mr proADM ) addition clinical evaluation effective predict outcome acute exacerbation COPD patient visit emergency room ( ER ) .</brief_summary>
	<brief_title>Prognosis Value Pro-adrenomedullin Acute Exacerbations COPD ER</brief_title>
	<detailed_description>Acute exacerbation COPD ( AECOPD ) usual frequent cause admission emergency room ( ER ) . No validated clinical biological predictor evolution available . The main objective determine prognosis value Mr proADM addition clinical risk stratification AE COPD patient ER . Patients present AECOPD diagnosis ER blood sample collect freezed admission . Mr proADM assess end study . Clinicians charge patient result management patient . This study imply change patient ' management . Data related patients'demographic , current exacerbation basic COPD characteristic collect .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Adrenomedullin</mesh_term>
	<criteria>patient &gt; 40 year old Acute exacerbation COPD Medico social condition allow home discharge Other cause Dyspnea : Pneumothorax , pulmonary embolism , pulmonary oedema , lung cancer Pneumonia chest ray acute respiratory distress require immediate ICU transfer</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>AECOPD Mr ProADM Biomarkers ER Outcome</keyword>
</DOC>